Washington - (Saba):
A recent scientific study has shown promising results for a new treatment that may restore vision by stimulating retinal cell regeneration using antibodies.
Researchers from South Korea explained that the treatment relies on blocking the "Prox1" protein, which prevents nerve cells from regenerating, allowing laboratory mice to regain some visual function.
Despite the positive results, the study confirmed that the treatment is still in the preclinical stage, and human trials are expected to begin by 2028.
In a related development, a team from Brown University in the United States has developed a technology based on gold nanoparticles injected into the eye and activated by a laser to stimulate visual cells, without the need for complex surgical procedures.
Researchers hope these discoveries will transform the treatment of degenerative retinal diseases such as age-related macular degeneration.
| more of (International) |